# KLF16

## Overview
KLF16, or Krüppel-like factor 16, is a gene that encodes a transcription factor belonging to the Krüppel-like factor family, characterized by its zinc finger motifs. The KLF16 protein plays a pivotal role in regulating gene expression by binding to GC-rich sequences in the promoters of target genes. It is involved in various biological processes, including lipid metabolism, redox balance, and cell cycle regulation, primarily through its interactions with other proteins and transcriptional co-regulators (Sun2020Hepatic; Chen2010Porcine). KLF16's function is modulated by post-translational modifications and alternative splicing, which contribute to its versatility in cellular processes (FernandezZapico2011A). The gene's dysregulation has been implicated in several diseases, including metabolic disorders and cancers, highlighting its clinical significance (Sun2020Hepatic; Zhang2020KLF16).

## Structure
KLF16, a member of the Krüppel-like factor family, is characterized by a highly conserved DNA-binding domain composed of three tandem Cys2-His2 zinc fingers located at the C-terminus. These zinc fingers are crucial for binding to GC-rich sequences in target gene promoters, facilitating the protein's role as a transcription factor (Shao2016Characterization; Chen2010Porcine). The zinc finger domain is a defining feature of KLF16, contributing to its secondary and tertiary structures (Suske2005Mammalian).

The N-terminal region of KLF16 is more variable and contains domains that interact with transcriptional co-regulators, such as the Sin3A co-repressor complex, which is involved in histone deacetylase activity (Swamynathan2010Krüppellike). This interaction suggests a role in transcriptional repression, aligning with its function in cell cycle regulation (Shao2016Characterization).

KLF16 may undergo post-translational modifications, such as phosphorylation, which can influence its activity and stability. Alternative splicing of the KLF16 gene can result in different isoforms, potentially affecting its function and interactions with other proteins (FernandezZapico2011A). These structural features and modifications underscore the functional versatility of KLF16 in cellular processes.

## Function
KLF16 (Kruppel-like factor 16) is a transcription factor that plays a significant role in regulating hepatic lipid metabolism and maintaining redox balance. In healthy liver cells, KLF16 is involved in promoting fatty acid oxidation and reducing lipid accumulation, primarily through its interaction with the peroxisome proliferator-activated receptor alpha (PPARα) pathway. KLF16 directly binds to the promoter region of PPARα, enhancing the expression of PPARα and its target genes, which are crucial for fatty acid metabolism (Sun2020Hepatic).

KLF16 overexpression in hepatocytes has been shown to alleviate hepatic steatosis by increasing fatty acid oxidation and improving glucose and insulin tolerance. It also enhances mitochondrial biogenesis and reduces reactive oxygen species (ROS) production, indicating its role in maintaining intracellular redox balance (Sun2020Hepatic). KLF16 acts as a negative regulator of proinflammatory genes in the liver, protecting against hepatocyte apoptosis and reducing oxidative stress and inflammation (Sun2020Hepatic).

In the context of liver metabolism, KLF16 deficiency leads to increased lipid accumulation and ROS production, which can be mitigated by PPARα overexpression, highlighting the importance of the KLF16-PPARα pathway in maintaining hepatic lipid homeostasis (Sun2020Hepatic).

## Clinical Significance
KLF16 (Kruppel-like factor 16) has been implicated in various diseases due to alterations in its expression levels and interactions. In breast cancer, KLF16 is overexpressed, particularly in triple-negative breast cancer, and is associated with poor prognosis and disease-free survival rates. Its overexpression promotes cell proliferation, migration, and invasion, suggesting an oncogenic role (The; Bang2020&lt; p&gt). In prostate cancer, KLF16 is upregulated and linked to cell cycle progression and tumor growth, influencing MYC signaling pathways (KLF16; p&gt; Zhang2020&lt). 

In retinoblastoma, KLF16 acts as an oncogene by promoting cell proliferation and migration while inhibiting apoptosis through the repression of the BCL2L15 gene (Zhang2020KLF16). KLF16 is also involved in gastric and bladder cancers, where it promotes tumor growth and metastasis by activating the NOTCH pathway and inhibiting TGF-b receptor 3, respectively (Zhang2023Krüppellike). 

In metabolic disorders, KLF16 expression is decreased in non-alcoholic fatty liver disease (NAFLD), leading to impaired lipid metabolism and increased insulin resistance. Its role in regulating PPARα is crucial for maintaining lipid homeostasis and reducing oxidative stress (Sun2020Hepatic).

## Interactions
KLF16 interacts with various proteins and nucleic acids, playing a significant role in gene regulation. It forms complexes with the Sin3 protein complex, specifically interacting with the Sin3 PAH2 domain. This interaction is crucial for transcriptional silencing, as KLF16's Sin3 interaction domain (SID) docks into the PAH2 domain in an N to C terminus orientation, with its hydrophobic face positioned within the Sin3 hydrophobic pocket. This interaction involves specific residues such as Tyr-10, Phe-11, and Ala-12, and mutations in these residues can disrupt the interaction (Daftary2012Detailed).

KLF16 also interacts with the peroxisome proliferator-activated receptor alpha (PPARα) in hepatic cells. It binds directly to the promoter region of PPARα, enhancing its expression and promoting fatty acid oxidation. This interaction is significant in reducing hepatic lipid load and improving conditions like steatohepatitis and insulin resistance (Sun2020Hepatic).

In the context of epithelial-mesenchymal transition (EMT) and cancer progression, KLF16 regulates Twist1 expression by binding to its promoter. This interaction is essential for the upregulation of Twist1 by SF3B4, highlighting KLF16's role in cell migration and invasion (Yang2023SF3B4).


## References


[1. (Zhang2020KLF16) Jing-xue Zhang, Xue-jing Yan, Shen Wu, Qian Liu, and Jian-min Ma. Klf16 overexpression deleteriously affects the proliferation and migration of retinoblastoma by transcriptionally repressing bcl2l15. Biochemical and Biophysical Research Communications, 529(4):977–983, September 2020. URL: http://dx.doi.org/10.1016/j.bbrc.2020.06.027, doi:10.1016/j.bbrc.2020.06.027. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2020.06.027)

[2. (FernandezZapico2011A) Martin E. Fernandez-Zapico, Gwen A. Lomberk, Shoichiro Tsuji, Cathrine J. DeMars, Michael R. Bardsley, Yi-Hui Lin, Luciana L. Almada, Jing-Jing Han, Debabrata Mukhopadhyay, Tamas Ordog, Navtej S. Buttar, and Raul Urrutia. A functional family-wide screening of sp/klf proteins identifies a subset of suppressors of kras-mediated cell growth. Biochemical Journal, 435(2):529–537, March 2011. URL: http://dx.doi.org/10.1042/bj20100773, doi:10.1042/bj20100773. This article has 75 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20100773)

[3. (Shao2016Characterization) Ming Shao, Guang-Zhe Ge, Wen-Jing Liu, Ji Xiao, Hou-Jun Xia, Yu Fan, Feng Zhao, Bao-Li He, and Ceshi Chen. Characterization and phylogenetic analysis of krüppel-like transcription factor (klf) gene family in tree shrews (tupaia belangeri chinensis). Oncotarget, 8(10):16325–16339, December 2016. URL: http://dx.doi.org/10.18632/oncotarget.13883, doi:10.18632/oncotarget.13883. This article has 17 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.13883)

[4. (Zhang2023Krüppellike) Yuchen Zhang, Chongjie Yao, Ziyong Ju, Danli Jiao, Dan Hu, Li Qi, Shimin Liu, Xueqing Wu, and Chen Zhao. Krüppel-like factors in tumors: key regulators and therapeutic avenues. Frontiers in Oncology, January 2023. URL: http://dx.doi.org/10.3389/fonc.2023.1080720, doi:10.3389/fonc.2023.1080720. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2023.1080720)

[5. (Suske2005Mammalian) Guntram Suske, Elspeth Bruford, and Sjaak Philipsen. Mammalian sp/klf transcription factors: bring in the family. Genomics, 85(5):551–556, May 2005. URL: http://dx.doi.org/10.1016/j.ygeno.2005.01.005, doi:10.1016/j.ygeno.2005.01.005. This article has 309 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2005.01.005)

[6. (Yang2023SF3B4) Zhan Yang, Ya-Xuan Wang, Jin-Kun Wen, Hai-Tao Gao, Zhen-Wei Han, Jin-Chun Qi, Jun-Fei Gu, Chen-Ming Zhao, Hong Zhang, Bei Shi, Dan-Dan Wang, Xiao-Lu Wang, and Chang-Bao Qu. Sf3b4 promotes twist1 expression and clear cell renal cell carcinoma progression by facilitating the export of klf 16 mrna from the nucleus to the cytoplasm. Cell Death &amp; Disease, January 2023. URL: http://dx.doi.org/10.1038/s41419-022-05534-w, doi:10.1038/s41419-022-05534-w. This article has 6 citations.](https://doi.org/10.1038/s41419-022-05534-w)

[7. (Swamynathan2010Krüppellike) Shivalingappa K Swamynathan. Krüppel-like factors: three fingers in control. Human Genomics, 4(4):263, 2010. URL: http://dx.doi.org/10.1186/1479-7364-4-4-263, doi:10.1186/1479-7364-4-4-263. This article has 71 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1479-7364-4-4-263)

[8. (Chen2010Porcine) Zhilong Chen, Ting Lei, Xiaodong Chen, Jian Zhang, An Yu, Qinqiang Long, Huan Long, Dan Jin, Li Gan, and Zaiqing Yang. Porcine klf gene family: structure, mapping, and phylogenetic analysis. Genomics, 95(2):111–119, February 2010. URL: http://dx.doi.org/10.1016/j.ygeno.2009.11.001, doi:10.1016/j.ygeno.2009.11.001. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2009.11.001)

[9. (Sun2020Hepatic) Nannan Sun, Chuangpeng Shen, Lei Zhang, Xiaojie Wu, Yuanyuan Yu, Xiaoying Yang, Chen Yang, Chong Zhong, Zhao Gao, Wei Miao, Zehong Yang, Weihang Gao, Ling Hu, Kevin Williams, Changhui Liu, Yongsheng Chang, and Yong Gao. Hepatic krüppel-like factor 16 (klf16) targets pparα to improve steatohepatitis and insulin resistance. Gut, 70(11):2183–2195, November 2020. URL: http://dx.doi.org/10.1136/gutjnl-2020-321774, doi:10.1136/gutjnl-2020-321774. This article has 69 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/gutjnl-2020-321774)

[10. (Daftary2012Detailed) Gaurang S. Daftary, Gwen A. Lomberk, Navtej S. Buttar, Thomas W. Allen, Adrienne Grzenda, Jinsan Zhang, Ye Zheng, Angela J. Mathison, Ravi P. Gada, Ezequiel Calvo, Juan L. Iovanna, Daniel D. Billadeau, Franklyn G. Prendergast, and Raul Urrutia. Detailed structural-functional analysis of the krüppel-like factor 16 (klf16) transcription factor reveals novel mechanisms for silencing sp/klf sites involved in metabolism and endocrinology. Journal of Biological Chemistry, 287(10):7010–7025, March 2012. URL: http://dx.doi.org/10.1074/jbc.m111.266007, doi:10.1074/jbc.m111.266007. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m111.266007)